Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Letter From The Editor

Editor's Note, DCMS #255

We have been at the U.S. Pro Challenge in Colorado this past week and after seven grueling days and 865 miles, Javier Megias of...


Editor's Note, SGLT-2 Inhibitors Special Edition, August 2015

On Wednesday night, I was in Beverly Hills and was able to sit in on a presentation that a cardiologist was providing to a group of nurse practitioners...


Editor's Note, DCMS #254

Have you ever heard of nesidioblatosis? More importantly, have you ever put that condition together with diabetes? In our new Near...



Editor's Note, GLP-1 Analog Special Edition, August 2015

The use of GLP-1 analogs have become commonplace in the prescribers' regimen and many practitioners try different combinations to maximize the potential of this class of drugs. Using a GLP-1 analog with basal insulin has become the norm and this...


Editor's Note, DCMS #253

Every day, more and more of our patients start on insulin. In past years, most of these patients were started on basal insulin by their primary care prescriber and then titrated up. However, when it came to adding on meal time insulin, they...


Letter from the Editor, #796

Often when a diabetes patient goes out of the house, they have a whole backpack full of stuff, including meters, strips, lancets, glucose tabs, insulin pens or extra pump sets, a cell phone and maybe a CGMS device. Keeping up with their bag...


Letter from the Editor, #795

This week we have lots of information for you. We continue to see the value of individualizing diabetes care for every patient and there is no better way to show you this than to share a couple of interviews I had this week at the U.S. Pro...


Letter from the Editor, #794

There are some diabetes patients who push the limits on living a normal life, and even go beyond normal to the extreme. They push their bodies to achievements that even the best euglycemic patient can only dream of coming close to. One group of...


Letter from the Editor, #793

Sometimes it seems that we get our priorities screwed up. Earlier in the week, I had to teach a patient how to dose NPH and Regular insulin to manage their diabetes. This does not seem like much except this patient has been well-controlled...


Editor's Note, DCMS #252

As soon as we see a person who has diabetes, we decide that hypertension will be a problem. In fact about 74% of diabetes patients do have elevated blood pressure levels. The problem with this is that often we put type 1 patients in that group...


Letter from the Editor, #792

Ever since we were at the ADA meeting in Boston, there has been a lot of buzz about the artificial pancreas and how great it will be. We have even provided you with exclusive interviews...


Editor's Note, SGLT-2 Inhibitors Special Edition, July 2015

This week, the editorial staff was assigned the task of reviewing our Homerun slides. We have so many in the archives that we had to split them up just to get them all covered. While looking at them, one of our production editors found a...


Editor's Note, DCMS #251

  Today I got to see a referral in an Endo’s office. The patient had been referred by the primary care physician because he was on high dose Lantus and not in control. I asked my intern what she recommended and the suggestion came ...


Letter from the Editor, #791

If you get diabetes when you are 60 years old, the odds of developing kidney disease in your lifetime is low. However, if you are diagnosed when you are in your 30s or 40s, the risk is increased, and the likelihood of needing dialysis is greatly...


Editor's Note, DCMS #250

The drug reps for DPP-4 inhibitors, GLP-1 agonists, and various insulins have been having a field day talking to prescribers about the possible cardiovascular effects of SGLT-2 inhibitors. This along with the relatively small risk of UTI's has...


Editor's Note, GLP-1 Analog Special Edition, July 2015

Often when I see a patient who has started on basal insulin, they seem to do okay. But as the prescriber starts to increase the basal dose to gain A1c control, the patient frequently gain weight and that can increase non-adherence to medications....


Letter from the Editor, #790

Last Monday night I was delivering a CE on MTM and Med Errors to a group of pharmacists in Tampa. As I was delving into the reasons for MTM (Medication Therapy Management), I was enlightening the younger pharmacists on ways that our profession has...


Editor's Note, DCMS #249

Charcot neuroarthropathy is a serious and poorly understood condition associated with rapid destruction of bones and joints, and resulting in bone fragmentation. It is almost as if the foot implodes for no reason. Patients who deteriorate to that...


Letter from the Editor, #789

Our good friend David Kliff at Diabetes Investor has had diabetes for many years. He has been watching trends in the diabetes business for a long time and has an unique perspective on the business of diabetes that we often don't see. He has...


Editor's Note, DCMS #248

Over the past 15 years, Steve and I have read many a study, article, or abstract on curing type 1 diabetes. Although many of these have shown great promise and have had some serious backing from large companies and universities, none of them have...


Letter from the Editor, #788

Last week I was in the checkout lane at a grocery store and noticed how many magazines there were for diabetes and weight loss. It seems that almost every one of the headlines had something to do with eating more fat to lose weight. I looked at the...


Editor's Note, DCMS #247

For 20 years, we at Diabetes in Control have attended the ADA Scientific Sessions. Each year there are great research presentations and these always include two topics: the artificial pancreas and the cure for type 1 diabetes. Most of the...


Letter from the Editor, #787

This past week, the U.S. Supreme Court decided that federal exchanges for the Affordable Care Act were in accordance with the guidelines of the Act and millions of patients will be able to still have healthcare that otherwise would be left out. It...


Editor's Note, DCMS #246

Sometimes clinicians focus on things that we would not expect. Last week we had a little bit of information in our Homerun Slides about pramlintide. The response to these slides actually caught us by surprise and so this week we have...


Editor's Note, SGLT-2 Inhibitors Special Edition, June 2015

There has been a lot of press and discussion about using SGLT-2 inhibitors in type 1 diabetes due to the risk of DKA. Many of these articles focused on what happened to patients when they got DKA and whether it could be shown if the relationship...


Letter from the Editor, #786

When we were reviewing the data and presentations from the recent ADA Scientific Sessions we were commenting on how often a study comes out at this meeting that lends credibility to what you are already doing. This week we have a new study that...


Editor's Note, GLP-1 Analog Special Edition, June 2015

When a new idea comes along in medicine usually the clinician who first came up with the idea is ostracized by his or her less adventerous colleagues. There is nowhere this is more obvious than in the diabetes arena. One of our board...


Editor's Note, DCMS #245

This morning I had a new PharmD candidate start a rotation with me. As is customary with all my interns, I spent the first few hours getting them out of "textbook/multiple choice" mode and into "patient care" mode. During the...


Letter from the Editor, #785

One of the best things that happens at the ADA is the chance to interact with our Advisory Board members. When Steve and I started this publication 15 years ago,...


Editor's Note, DCMS #244

We've been at the ADA Scientific Sessions in Boston for the last four days where we garnered more than 20 interviews with top thinkers in diabetes. We will be bringing you this great information over the next few months. One of our favorite...


Letter from the Editor, #784

Sometimes some of us get frustrated because it seems that studies have to be done to support the obvious, but I realize that others need experts to validate what seems so simple to try to the rest of us. As a Diabetes Educator talking to...


Editor's Note, DCMS #243

When we talk about the complications of diabetes we frequently talk about kidney failure and amputation, but more often than not the first changes that a patient notices are in their vision. Whether it is difficulty reading because of elevated...


Letter from the Editor, #783

Last week in our SGLT- Inhibitor Special Edition for May, we discussed the idea of early adopters using the complete arsenal of diabetes...


Editor's Note, SGLT-2 Inhibitors Special Edition, May 2015

Sometimes the early adopters receive a little scorn from their colleagues for "jumping on the bandwagon" too early. However it seems that usually sooner or later everyone else comes over to their way of thinking and the...


Editor's Note, DCMS #242

We often threaten our patients with the complications of diabetes to try to get them to work on their diabetes. Kidney failure and dialysis are the most scary ones that we can talk about. But what happens when we finally have to start a patient on...


Letter from the Editor, #782

Steve and I got a chance to talk to Edward Damiano, PhD, from Boston University about his work on the "Bionic Pancreas" while we were at the recent AACE meeting in Nashville. We have all seen a lot of information using CGMS and an insulin...


Editor's Note, GLP-1 Analogs May 2015 Special Edition

This past weekend I was at the ADA regional meeting in Orlando. There were over 600 medical professional attendees, and over 40 presentations on medications and of those 28 had content on GLP-1 analogs. I got a chance to share with 200 attendees...


Editor's Note, DCMS #241

We have been at the AACE meeting in Nashville, and the information presented was overwhelming to say the least. Between Steve, Joy, and I we interviewed over 40 thought leaders, practitioners, and researchers so that we can bring you the best of...


Letter from the Editor, #781

Steve, Joy and I are spending our time at the 24th Annual Scientific and Clinical Conference of the American Association of Clinical Endocrinologists in Nashville, Tennessee. We have spent four days reviewing posters and...


Editor's Desk, DCMS #240

When I am discussing the value of physical activity with patients I will often start bending my left ring finger repeatedly and tell the patients that, "I can lower glucose just by doing this. However it is a small muscle and it will take a...



Navigate through our listing of Letter From The Editor articles here.
Next Last

666 Total articles for Letter From The Editor


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here


Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Lois Exelbert,
RN, CDE, BC-ADM, LCCE

Category: Nursing
Credits: 1


Advertisement